Cargando…

Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography

BACKGROUND: Leptospirosis is an emerging zoonosis that affects humans and animals. Immunochromatography rapid test is widely used for early diagnosis of leptospirosis, but with low sensitivity and specificity. OBJECTIVES: To evaluate Leptospira interrogans insoluble fraction as a potential antigen s...

Descripción completa

Detalles Bibliográficos
Autores principales: Campos, Hevandro de Souza, da Silva, Edimilson Domingos, de Lima, Gerson Silva, Resende, Rafael de Oliveira, Burth, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Oswaldo Cruz, Ministério da Saúde 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187047/
https://www.ncbi.nlm.nih.gov/pubmed/37194802
http://dx.doi.org/10.1590/0074-02760220265
_version_ 1785042676928741376
author Campos, Hevandro de Souza
da Silva, Edimilson Domingos
de Lima, Gerson Silva
Resende, Rafael de Oliveira
Burth, Patricia
author_facet Campos, Hevandro de Souza
da Silva, Edimilson Domingos
de Lima, Gerson Silva
Resende, Rafael de Oliveira
Burth, Patricia
author_sort Campos, Hevandro de Souza
collection PubMed
description BACKGROUND: Leptospirosis is an emerging zoonosis that affects humans and animals. Immunochromatography rapid test is widely used for early diagnosis of leptospirosis, but with low sensitivity and specificity. OBJECTIVES: To evaluate Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography. METHODS: Insoluble fraction derived from the crude bacterial extract was obtained by serial centrifugation. The polypeptide profile was determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Immune reactivity of this fraction was assessed by Western Blotting and lateral flow immunochromatography (LFI). It was tested 160 microagglutination test (MAT)-positive sera from patients in the acute phase, 100 MAT-negative sera from patients with acute febrile illness, and 45 patients with other infectious diseases. FINDINGS: There was a predominance of low molecular mass-polypeptide bands, ranging from 2 to 37 kDa. The antibody reactivity of theses polypeptides was found to range from 13-50%, especially between 10 and 38 kDa. Among MAT-positive sera of patients with leptospirosis in the acute phase, 97% were also positive in LFI, indicating high sensitivity. Among MAT-negative sera, all were negative in LFI, indicating high specificity. Only 2% of cross-reactivity was detected. CONCLUSION: The insoluble fraction can be a valuable antigen source for development of point-of-care diagnosis test for leptospirosis.
format Online
Article
Text
id pubmed-10187047
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Instituto Oswaldo Cruz, Ministério da Saúde
record_format MEDLINE/PubMed
spelling pubmed-101870472023-05-17 Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography Campos, Hevandro de Souza da Silva, Edimilson Domingos de Lima, Gerson Silva Resende, Rafael de Oliveira Burth, Patricia Mem Inst Oswaldo Cruz Research Article BACKGROUND: Leptospirosis is an emerging zoonosis that affects humans and animals. Immunochromatography rapid test is widely used for early diagnosis of leptospirosis, but with low sensitivity and specificity. OBJECTIVES: To evaluate Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography. METHODS: Insoluble fraction derived from the crude bacterial extract was obtained by serial centrifugation. The polypeptide profile was determined using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Immune reactivity of this fraction was assessed by Western Blotting and lateral flow immunochromatography (LFI). It was tested 160 microagglutination test (MAT)-positive sera from patients in the acute phase, 100 MAT-negative sera from patients with acute febrile illness, and 45 patients with other infectious diseases. FINDINGS: There was a predominance of low molecular mass-polypeptide bands, ranging from 2 to 37 kDa. The antibody reactivity of theses polypeptides was found to range from 13-50%, especially between 10 and 38 kDa. Among MAT-positive sera of patients with leptospirosis in the acute phase, 97% were also positive in LFI, indicating high sensitivity. Among MAT-negative sera, all were negative in LFI, indicating high specificity. Only 2% of cross-reactivity was detected. CONCLUSION: The insoluble fraction can be a valuable antigen source for development of point-of-care diagnosis test for leptospirosis. Instituto Oswaldo Cruz, Ministério da Saúde 2023-05-12 /pmc/articles/PMC10187047/ /pubmed/37194802 http://dx.doi.org/10.1590/0074-02760220265 Text en https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License
spellingShingle Research Article
Campos, Hevandro de Souza
da Silva, Edimilson Domingos
de Lima, Gerson Silva
Resende, Rafael de Oliveira
Burth, Patricia
Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title_full Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title_fullStr Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title_full_unstemmed Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title_short Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
title_sort leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10187047/
https://www.ncbi.nlm.nih.gov/pubmed/37194802
http://dx.doi.org/10.1590/0074-02760220265
work_keys_str_mv AT camposhevandrodesouza leptospirainterrogansinsolublefractionasapotentialantigensourceforlateralflowimmunochromatography
AT dasilvaedimilsondomingos leptospirainterrogansinsolublefractionasapotentialantigensourceforlateralflowimmunochromatography
AT delimagersonsilva leptospirainterrogansinsolublefractionasapotentialantigensourceforlateralflowimmunochromatography
AT resenderafaeldeoliveira leptospirainterrogansinsolublefractionasapotentialantigensourceforlateralflowimmunochromatography
AT burthpatricia leptospirainterrogansinsolublefractionasapotentialantigensourceforlateralflowimmunochromatography